Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
One Codex
AddedMar 17, 2024
UpdatedJul 3, 2026
One Codex

One Codex

Acquired

Microbial genomics data platform for various applications. Acquired by Invitae, now independent.

Founded
2014
Accelerator
Y Combinator logoY CombinatorS14
Overview
Compare
Fundraising
Employees

One Codex, founded with a mission to advance microbial genomics, offers a comprehensive data platform for metagenomics and microbiome analysis. The company focuses on enabling applications in clinical diagnostics, food safety, and biosecurity. By providing robust tools for microbial identification and analysis, One Codex aims to transform how microbial data is utilized across these critical sectors.

Notable achievements include its acquisition by Invitae in February 2021 and subsequent re-establishment as an independent entity in September 2022. The platform has significantly impacted the fields of clinical diagnostics and food safety by offering precise and scalable genomic solutions. Key affiliated individuals and investors are not publicly detailed, but the company's innovations continue to drive advancements in microbial genomics.

One Codex - Similar Companies

Cornerstone Genomics logo

Cornerstone Genomics

Genomelink logo

Genomelink

genomelink.io

Genomenon logo

Genomenon

genomenon.com

Biomiic logo

Biomiic

Cosmosid logo

Cosmosid

cosmosid.com

Aperiomics logo

Aperiomics

Nest Genomics logo

Nest Genomics

nestgenomics.com

CapForce logo

CapForce

opgen.com

Streamline Genomics logo

Streamline Genomics

GenomeNext logo

GenomeNext

Bioinfoexperts logo

Bioinfoexperts

bioinfox.com

Canomiks logo

Canomiks

canomiks.com

Clear Labs logo

Clear Labs

clearlabs.com

Data Driven Bioscience logo

Data Driven Bioscience

Basepair logo

Basepair

basepairtech.com

One Codex - Quick Facts

Who are One Codex's competitors?

Companies similar to One Codex include Cornerstone Genomics, Genomelink, Genomenon and Biomiic.

When was One Codex founded?

One Codex was founded in 2014.

When was One Codex's last funding round?

One Codex's most recent funding round was for $120k (USD) in January 2014.

How much has One Codex raised to-date?

As of Jan 1, 2014, One Codex has raised a total of $120k (USD).

One Codex - Classification

Ownership
  • Private Equity
  • Venture Capital
Technology
  • Analytics
  • Biotech
Geographic Exposure
  • Global
Model
  • Platform
Revenue
  • Recurring
  • SaaS
  • Transactional
Customer
  • Enterprise
Main Product
  • Data Platform
  • Genomics
Tags
  • Biotech
  • Data